drugset / Trial / NCT07649369
A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to evaluate the efficacy and safety of intrapleural JMKX000197 compared with intrapleural cisplatin in patients with malignant pleural effusion.
Timeline
- Start
- 2026-08-17
- Primary completion
- 2028-01-12
- Completion
- 2028-08-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cisplatin | Other / unclassified | — | Other |
| Subject | JMKX000197 | Unknown | — | Other |